Home

Atabak Mokari

CIK 1678419 · Chief Financial Officer · last filed 2026-09-03

Atabak Mokari is a Chief Financial Officer who has filed 33 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for CORT, was dated Sep 3, 2026. Across all open-market trades the lifetime net is −$18.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.86M

Companies

3

Total Filings

33

Lifetime Open-Market Net

-$18.73M

Filer Profile

Reported Address
C/O CORCEPT THERAPEUTICS INCORPORATED
101 REDWOOD SHORES PARKWAY
REDWOOD CITY, CA 94065
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT Chief Financial Officer 16,304 $110.82 $1.81M -$18.73M 24 2026-09-03
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Chief Financial Officer — $0.07 — $0 3 2020-04-09
IRIX CFO and VP Corp Development 81,967 $0.63 $51.8K $0 4 2018-12-13

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-03 CORT Mixed +174 $4.1K EDGAR
2026-08-03 CORT Mixed — -$7.33M EDGAR
2026-07-30 CORT Notice (144) −40,000 -$4.59M EDGAR
2026-07-17 CORT Mixed — -$2.65M EDGAR
2026-06-17 CORT Mixed — -$2.48M EDGAR
2026-06-03 CORT Mixed +873 -$2.01M EDGAR
2026-06-01 CORT Notice (144) −160,000 -$11.20M EDGAR
2026-03-04 CORT Mixed +698 $10.8K EDGAR
2026-03-03 CORT Grant (A) — $0 EDGAR
2025-12-03 CORT Mixed +238 $4.8K EDGAR
Showing 1–10 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.